Medifast, Inc.
MED
$12.72
-$0.40-3.05%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -772.00K | 801.00K | 1.13M | -8.15M | 8.32M |
| Total Depreciation and Amortization | 3.28M | 12.38M | -6.00M | 3.07M | 3.26M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.67M | -13.25M | 12.76M | 19.14M | 767.00K |
| Change in Net Operating Assets | -1.77M | -4.88M | 1.18M | -984.00K | -5.06M |
| Cash from Operations | 3.41M | -4.95M | 9.07M | 13.07M | 7.28M |
| Capital Expenditure | -1.52M | -2.29M | -1.39M | -1.94M | -1.84M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -532.00K | -17.15M | -392.00K | -594.00K | -934.00K |
| Cash from Investing | -2.05M | -19.43M | -1.78M | -2.53M | -2.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 36.00K |
| Repurchase of Common Stock | -369.00K | -1.00K | -2.00K | -16.00K | -817.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -194.00K | 0.00 | -1.00K | -4.00K | -710.00K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -563.00K | -1.00K | -3.00K | -20.00K | -1.49M |
| Foreign Exchange rate Adjustments | -- | 0.00 | 4.00K | 28.00K | 15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 789.00K | -24.38M | 7.29M | 10.55M | 3.03M |